DCM
AUPH icon

Dupont Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Dupont Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,730
Closed -$24.8K – 791
2022
Q4 		$24.8K Sell
5,730
-15,972
-74% -$92.7K ﹤0.01% 1111
2022
Q3 		$163K Buy
21,702
+12,857
+145% +$111K 0.01% 921
2022
Q2 		$89K Hold
8,845
– – ﹤0.01% 1203
2022
Q1 		$110K Buy
8,845
+233
+3% +$3.6K ﹤0.01% 1239
2021
Q4 		$197K Sell
8,612
-4,785
-36% -$113K 0.01% 1112
2021
Q3 		$296K Buy
+13,397
New +$213K 0.01% 1078

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dupont Capital Management's AUPH Position: Q1 2023 in Review

Dupont Capital Management sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2023, closing a stake of 5,730 shares — an estimated $24.8K sold.

Dupont Capital Management first reported a position in AUPH in Q3 2021 and held it in 6 quarters. The position peaked at $296K in Q3 2021. 186 funds tracked by Wall St. Rank hold AUPH as of Q1 2023.

  • Dupont Capital Management reported no remaining Aurinia Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 5,730 Aurinia Pharmaceuticals shares in Q1 2023, an estimated $24.8K.
  • Dupont Capital Management first reported a position in Aurinia Pharmaceuticals in Q3 2021 and held it in 6 quarters.
  • Dupont Capital Management's Aurinia Pharmaceuticals position peaked at $296K in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.